CRCT - Centre de Recherches en Cancérologie de Toulouse

Type : Rapport d’évaluation des unités de recherche

Campagne d'évaluation : 2019-2020 (vague A) - Publié le : 26/02/2020

Établissement(s) concerné(s) : Centre national de la recherche scientifique - CNRS , Institut national de la santé et de la recherche médicale - INSERM , Université Toulouse 3 - Paul Sabatier - UPS

Domaine(s) disciplinaire(s) de recherche : Sciences de la vie et de la terre (SVE)

Domaine(s) scientifique(s) : 5 - Biologie, medecine et santé

Panel(s) ERC : LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome ; LS6 Immunity and infection: immunobiology, aetiology of immune disorders, microbiology, virology, parasitology, global and other infectious diseases, population dynamics of infectious diseases, veterinary medicine, LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction, LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics

Nom des équipes de l'unité : Genomics and Immunology of Myeloma ; Tumor immunity and immunotherapy ; MICROENVIRONMENT & THERAPEUTIC RESISTANCE IN PANCREATIC NEOPLASMS ; Dose individualization of anticancer drugs ; Oncogenesis of sarcomas ; Therapeutic innovation in pancreatic cancer ; Alteration of transcription factors in acute leukemias ; Cancer Cell Signaling and Therapeutics ; Integrated cell signalling and class I-II-III isoforms of PI3K ; Novel Lymphoma Immuno-Therapeutics ; RNA-binding proteins & genotoxic stress ; Optimization of radiotherapy: from mechanisms to clinical trials ; Cholesterol metabolism and therapeutic innovations ; RNA Biology in Hematological Tumors ; Metabolism and drug resistance in acute myeloid leukemia ; Ceramide metabolism in melanoma: from basic mechanisms to immunotherapy ; Molecular Dynamics of Lymphocyte Interactions

Mot(s) clé(s) : Hémopathies malignes ; cancers du pancréas ; cancers du sein ; cancers du poumon Oncogénèse ; génétique ; oncométabolisme ; microenvironnement ; onco-immunologie ; thérapeutique et résistance ; biomarqueurs